| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Celiac Disease | 58 | 2024 | 219 | 9.700 |
Why?
|
| Interleukin-15 | 22 | 2020 | 75 | 4.250 |
Why?
|
| Intestinal Mucosa | 42 | 2025 | 825 | 3.220 |
Why?
|
| Glutens | 23 | 2024 | 86 | 2.610 |
Why?
|
| Autoimmune Diseases | 10 | 2024 | 255 | 2.380 |
Why?
|
| Immunity, Innate | 12 | 2024 | 463 | 2.340 |
Why?
|
| T-Lymphocytes, Cytotoxic | 11 | 2022 | 319 | 2.130 |
Why?
|
| Killer Cells, Natural | 13 | 2024 | 287 | 1.740 |
Why?
|
| Receptors, Antigen, T-Cell | 11 | 2021 | 424 | 1.360 |
Why?
|
| CD4-Positive T-Lymphocytes | 12 | 2024 | 481 | 1.340 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 7 | 2015 | 35 | 1.340 |
Why?
|
| Self Tolerance | 3 | 2024 | 26 | 1.310 |
Why?
|
| Intestines | 6 | 2025 | 433 | 1.280 |
Why?
|
| Intestine, Small | 12 | 2023 | 311 | 1.250 |
Why?
|
| T-Lymphocytes | 20 | 2023 | 1276 | 1.220 |
Why?
|
| Cholangitis, Sclerosing | 4 | 2024 | 54 | 1.200 |
Why?
|
| Autoimmunity | 8 | 2024 | 191 | 1.190 |
Why?
|
| HLA-DQ Antigens | 8 | 2020 | 51 | 1.170 |
Why?
|
| Interferon-gamma | 8 | 2023 | 459 | 1.130 |
Why?
|
| Gastrointestinal Microbiome | 14 | 2025 | 595 | 1.130 |
Why?
|
| Epithelial Cells | 6 | 2023 | 700 | 1.130 |
Why?
|
| Autoantigens | 2 | 2024 | 138 | 1.110 |
Why?
|
| Immunoglobulin A | 3 | 2025 | 89 | 1.100 |
Why?
|
| Inflammation | 11 | 2023 | 1049 | 1.090 |
Why?
|
| Receptors, Immunologic | 8 | 2017 | 139 | 1.000 |
Why?
|
| T-Lymphocyte Subsets | 5 | 2021 | 288 | 0.980 |
Why?
|
| Th1 Cells | 6 | 2018 | 166 | 0.970 |
Why?
|
| Colon | 8 | 2023 | 540 | 0.970 |
Why?
|
| Antigen Presentation | 4 | 2024 | 230 | 0.960 |
Why?
|
| Homeostasis | 5 | 2025 | 459 | 0.960 |
Why?
|
| Colitis | 6 | 2025 | 260 | 0.950 |
Why?
|
| Animals | 65 | 2025 | 27973 | 0.940 |
Why?
|
| Intraepithelial Lymphocytes | 6 | 2025 | 18 | 0.940 |
Why?
|
| Gliadin | 8 | 2022 | 17 | 0.910 |
Why?
|
| Antigens | 8 | 2023 | 223 | 0.900 |
Why?
|
| Microbiota | 6 | 2023 | 431 | 0.870 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 6 | 2019 | 111 | 0.860 |
Why?
|
| Immune Tolerance | 8 | 2023 | 378 | 0.860 |
Why?
|
| Humans | 110 | 2025 | 93138 | 0.850 |
Why?
|
| Signal Transduction | 16 | 2020 | 3497 | 0.830 |
Why?
|
| Inflammatory Bowel Diseases | 8 | 2025 | 647 | 0.820 |
Why?
|
| Mice | 44 | 2025 | 12230 | 0.800 |
Why?
|
| Desensitization, Immunologic | 1 | 2024 | 46 | 0.790 |
Why?
|
| Dendritic Cells | 7 | 2023 | 538 | 0.770 |
Why?
|
| Transglutaminases | 6 | 2021 | 41 | 0.760 |
Why?
|
| Mice, Inbred C57BL | 23 | 2025 | 3431 | 0.730 |
Why?
|
| Immune System | 2 | 2022 | 101 | 0.710 |
Why?
|
| Adaptive Immunity | 4 | 2021 | 179 | 0.710 |
Why?
|
| Phospholipases A2, Cytosolic | 2 | 2013 | 4 | 0.700 |
Why?
|
| Lymphocytes | 4 | 2018 | 453 | 0.700 |
Why?
|
| Histocompatibility Antigens Class I | 9 | 2018 | 207 | 0.650 |
Why?
|
| Lymphocyte Activation | 8 | 2018 | 798 | 0.640 |
Why?
|
| Epitopes, T-Lymphocyte | 5 | 2022 | 96 | 0.610 |
Why?
|
| Diet | 4 | 2023 | 461 | 0.590 |
Why?
|
| GTP-Binding Proteins | 4 | 2021 | 147 | 0.580 |
Why?
|
| HLA Antigens | 6 | 2019 | 228 | 0.580 |
Why?
|
| Caliciviridae Infections | 1 | 2018 | 10 | 0.570 |
Why?
|
| Norovirus | 1 | 2018 | 13 | 0.570 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily D | 4 | 2014 | 8 | 0.570 |
Why?
|
| Ovalbumin | 1 | 2018 | 103 | 0.560 |
Why?
|
| Colorectal Neoplasms | 2 | 2023 | 1054 | 0.550 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 4 | 2014 | 9 | 0.540 |
Why?
|
| Metagenome | 6 | 2025 | 116 | 0.540 |
Why?
|
| CD8-Positive T-Lymphocytes | 7 | 2019 | 660 | 0.530 |
Why?
|
| Cell Differentiation | 8 | 2024 | 1611 | 0.500 |
Why?
|
| Gene Expression Regulation | 7 | 2020 | 1980 | 0.470 |
Why?
|
| Vaccines | 2 | 2017 | 84 | 0.470 |
Why?
|
| Salmonella Infections | 1 | 2015 | 18 | 0.460 |
Why?
|
| Salmonella typhimurium | 1 | 2015 | 32 | 0.460 |
Why?
|
| Leukotrienes | 1 | 2015 | 20 | 0.460 |
Why?
|
| Models, Immunological | 7 | 2018 | 85 | 0.460 |
Why?
|
| Plague | 4 | 2008 | 27 | 0.460 |
Why?
|
| Capillary Permeability | 1 | 2015 | 131 | 0.440 |
Why?
|
| Food Hypersensitivity | 2 | 2019 | 81 | 0.440 |
Why?
|
| Immunity, Cellular | 1 | 2015 | 183 | 0.440 |
Why?
|
| Cysteine | 1 | 2015 | 145 | 0.430 |
Why?
|
| Yersinia pestis | 4 | 2008 | 24 | 0.420 |
Why?
|
| Cell Proliferation | 6 | 2019 | 1732 | 0.420 |
Why?
|
| Bacteria | 5 | 2025 | 508 | 0.400 |
Why?
|
| Crohn Disease | 5 | 2024 | 808 | 0.400 |
Why?
|
| Cytokines | 6 | 2020 | 862 | 0.400 |
Why?
|
| Cytoplasm | 1 | 2014 | 275 | 0.400 |
Why?
|
| Arthritis, Psoriatic | 1 | 2013 | 36 | 0.390 |
Why?
|
| Antigens, Bacterial | 3 | 2008 | 135 | 0.380 |
Why?
|
| Tumor Microenvironment | 3 | 2015 | 555 | 0.380 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2023 | 406 | 0.370 |
Why?
|
| Cells, Cultured | 12 | 2018 | 2827 | 0.370 |
Why?
|
| Yersinia Infections | 1 | 2012 | 5 | 0.370 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2012 | 7 | 0.370 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 304 | 0.370 |
Why?
|
| Yersinia enterocolitica | 1 | 2012 | 18 | 0.370 |
Why?
|
| Receptors, Interleukin-12 | 2 | 2011 | 9 | 0.360 |
Why?
|
| Th17 Cells | 2 | 2012 | 93 | 0.360 |
Why?
|
| Lectins, C-Type | 3 | 2014 | 71 | 0.360 |
Why?
|
| Administration, Oral | 5 | 2018 | 655 | 0.360 |
Why?
|
| Antigens, CD | 5 | 2017 | 476 | 0.360 |
Why?
|
| HEK293 Cells | 4 | 2019 | 696 | 0.360 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2024 | 2465 | 0.350 |
Why?
|
| Mice, Transgenic | 11 | 2022 | 1581 | 0.350 |
Why?
|
| Receptors, Natural Killer Cell | 6 | 2017 | 20 | 0.350 |
Why?
|
| NFATC Transcription Factors | 1 | 2011 | 50 | 0.350 |
Why?
|
| Interleukin-12 | 2 | 2011 | 107 | 0.350 |
Why?
|
| Disease Models, Animal | 9 | 2022 | 2479 | 0.340 |
Why?
|
| RNA, Untranslated | 1 | 2011 | 67 | 0.340 |
Why?
|
| Colitis, Ulcerative | 5 | 2024 | 800 | 0.340 |
Why?
|
| Interleukin-10 | 6 | 2019 | 163 | 0.330 |
Why?
|
| Immunity, Mucosal | 5 | 2023 | 71 | 0.320 |
Why?
|
| Tretinoin | 1 | 2011 | 128 | 0.320 |
Why?
|
| Pore Forming Cytotoxic Proteins | 3 | 2008 | 54 | 0.310 |
Why?
|
| Adjuvants, Immunologic | 1 | 2011 | 174 | 0.310 |
Why?
|
| Immunity | 3 | 2020 | 153 | 0.300 |
Why?
|
| Cell Nucleus | 1 | 2011 | 601 | 0.290 |
Why?
|
| Stress, Physiological | 2 | 2025 | 245 | 0.290 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2008 | 5 | 0.290 |
Why?
|
| Toll-Like Receptor 2 | 4 | 2018 | 36 | 0.290 |
Why?
|
| Membrane Proteins | 2 | 2018 | 1260 | 0.280 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 3 | 2018 | 113 | 0.280 |
Why?
|
| Ligands | 4 | 2022 | 476 | 0.280 |
Why?
|
| Immunotherapy | 2 | 2015 | 762 | 0.270 |
Why?
|
| Virulence Factors | 1 | 2008 | 113 | 0.270 |
Why?
|
| Reoviridae Infections | 2 | 2018 | 7 | 0.270 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 1339 | 0.260 |
Why?
|
| Immunologic Factors | 1 | 2008 | 175 | 0.250 |
Why?
|
| Mice, Knockout | 6 | 2024 | 2121 | 0.250 |
Why?
|
| Fecal Microbiota Transplantation | 4 | 2023 | 80 | 0.250 |
Why?
|
| Cell Line | 9 | 2019 | 2458 | 0.250 |
Why?
|
| Flow Cytometry | 7 | 2015 | 710 | 0.240 |
Why?
|
| Up-Regulation | 4 | 2019 | 727 | 0.240 |
Why?
|
| Autoantibodies | 4 | 2015 | 276 | 0.240 |
Why?
|
| Diet, Gluten-Free | 4 | 2019 | 60 | 0.240 |
Why?
|
| Phosphorylation | 4 | 2011 | 1129 | 0.240 |
Why?
|
| Butyrates | 2 | 2016 | 56 | 0.240 |
Why?
|
| Interferon Type I | 2 | 2025 | 163 | 0.230 |
Why?
|
| IgA Deficiency | 1 | 2025 | 2 | 0.220 |
Why?
|
| Bacterial Infections | 3 | 2018 | 178 | 0.220 |
Why?
|
| Case-Control Studies | 8 | 2019 | 1926 | 0.220 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 826 | 0.220 |
Why?
|
| Interleukin-15 Receptor alpha Subunit | 2 | 2015 | 6 | 0.220 |
Why?
|
| Germinal Center | 1 | 2025 | 62 | 0.210 |
Why?
|
| DNA-Binding Proteins | 2 | 2022 | 1231 | 0.210 |
Why?
|
| Dioxygenases | 2 | 2022 | 82 | 0.210 |
Why?
|
| Intestinal Neoplasms | 2 | 2002 | 68 | 0.210 |
Why?
|
| T-Lymphocytes, Regulatory | 5 | 2011 | 339 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2015 | 590 | 0.210 |
Why?
|
| Interleukin-1alpha | 1 | 2023 | 4 | 0.200 |
Why?
|
| Macrophages | 2 | 2023 | 609 | 0.200 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 26 | 0.200 |
Why?
|
| Inflammasomes | 1 | 2023 | 31 | 0.200 |
Why?
|
| Female | 30 | 2024 | 48547 | 0.200 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 88 | 0.200 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2023 | 113 | 0.200 |
Why?
|
| Complement Factor B | 1 | 2023 | 9 | 0.200 |
Why?
|
| Antigen-Presenting Cells | 1 | 2024 | 146 | 0.190 |
Why?
|
| Protein Binding | 3 | 2017 | 1526 | 0.190 |
Why?
|
| Antigens, CD1d | 2 | 2013 | 32 | 0.190 |
Why?
|
| Hematopoiesis | 2 | 2023 | 183 | 0.190 |
Why?
|
| T-Box Domain Proteins | 1 | 2024 | 127 | 0.190 |
Why?
|
| GATA4 Transcription Factor | 1 | 2023 | 19 | 0.190 |
Why?
|
| Adenosine Triphosphatases | 1 | 2023 | 140 | 0.190 |
Why?
|
| Sepsis | 2 | 2020 | 382 | 0.190 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 2889 | 0.190 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2023 | 24 | 0.190 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2002 | 8 | 0.190 |
Why?
|
| Goblet Cells | 1 | 2022 | 20 | 0.190 |
Why?
|
| Adenosine Triphosphate | 1 | 2023 | 312 | 0.190 |
Why?
|
| Male | 28 | 2024 | 44360 | 0.180 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2022 | 20 | 0.180 |
Why?
|
| Lymphocyte Count | 1 | 2022 | 98 | 0.180 |
Why?
|
| Neoplasms | 3 | 2013 | 3168 | 0.180 |
Why?
|
| RNA, Ribosomal, 16S | 6 | 2023 | 260 | 0.180 |
Why?
|
| Interferon Regulatory Factor-1 | 2 | 2018 | 18 | 0.180 |
Why?
|
| Orthoreovirus, Mammalian | 2 | 2018 | 2 | 0.180 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2023 | 538 | 0.170 |
Why?
|
| Germ-Free Life | 6 | 2019 | 84 | 0.170 |
Why?
|
| Urine | 1 | 2022 | 91 | 0.170 |
Why?
|
| Adult | 19 | 2024 | 27850 | 0.170 |
Why?
|
| CD28 Antigens | 1 | 2001 | 94 | 0.170 |
Why?
|
| Bone Marrow | 1 | 2023 | 408 | 0.170 |
Why?
|
| Amino Acid Sequence | 5 | 2022 | 1994 | 0.170 |
Why?
|
| Interleukin-23 | 2 | 2012 | 60 | 0.170 |
Why?
|
| Antigens, CD1 | 2 | 2007 | 37 | 0.160 |
Why?
|
| Chronic Disease | 2 | 2019 | 941 | 0.160 |
Why?
|
| Cell Communication | 2 | 2015 | 217 | 0.160 |
Why?
|
| Proteome | 1 | 2022 | 152 | 0.160 |
Why?
|
| Alarmins | 1 | 2020 | 6 | 0.160 |
Why?
|
| Dysbiosis | 2 | 2022 | 91 | 0.160 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2019 | 13 | 0.150 |
Why?
|
| Proteolysis | 2 | 2019 | 124 | 0.150 |
Why?
|
| Benzodiazepines | 1 | 2019 | 56 | 0.150 |
Why?
|
| Peptide Fragments | 2 | 2018 | 468 | 0.150 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2020 | 75 | 0.150 |
Why?
|
| Receptor, PAR-2 | 1 | 2019 | 3 | 0.150 |
Why?
|
| Adolescent | 10 | 2024 | 9550 | 0.150 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 204 | 0.150 |
Why?
|
| Epitopes | 2 | 2017 | 249 | 0.150 |
Why?
|
| Dietary Proteins | 1 | 2019 | 31 | 0.150 |
Why?
|
| Interleukins | 1 | 2019 | 133 | 0.140 |
Why?
|
| Butyrophilins | 1 | 2019 | 28 | 0.140 |
Why?
|
| Metalloendopeptidases | 1 | 2019 | 44 | 0.140 |
Why?
|
| Heat-Shock Proteins | 4 | 2016 | 177 | 0.140 |
Why?
|
| Child | 9 | 2024 | 7273 | 0.140 |
Why?
|
| Capsid Proteins | 1 | 2018 | 26 | 0.140 |
Why?
|
| Virus Shedding | 1 | 2018 | 19 | 0.140 |
Why?
|
| Amino Acids | 2 | 2023 | 245 | 0.140 |
Why?
|
| Liver | 2 | 2022 | 1206 | 0.140 |
Why?
|
| Interferon-alpha | 2 | 2018 | 187 | 0.140 |
Why?
|
| Histocompatibility Antigens Class II | 4 | 2018 | 171 | 0.140 |
Why?
|
| Coccidiosis | 1 | 2018 | 2 | 0.140 |
Why?
|
| Middle Aged | 17 | 2024 | 27539 | 0.140 |
Why?
|
| Mammalian orthoreovirus 3 | 1 | 2018 | 1 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2018 | 80 | 0.140 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2018 | 42 | 0.140 |
Why?
|
| Ileum | 1 | 2018 | 167 | 0.140 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 44 | 0.130 |
Why?
|
| Membrane Glycoproteins | 1 | 2000 | 443 | 0.130 |
Why?
|
| Micronutrients | 1 | 2017 | 18 | 0.130 |
Why?
|
| CD3 Complex | 4 | 2017 | 135 | 0.130 |
Why?
|
| Molecular Mimicry | 1 | 2017 | 17 | 0.130 |
Why?
|
| Endocytosis | 1 | 2018 | 184 | 0.130 |
Why?
|
| Immunohistochemistry | 3 | 2013 | 1786 | 0.130 |
Why?
|
| Feces | 4 | 2023 | 360 | 0.130 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 2009 | 215 | 0.130 |
Why?
|
| Young Adult | 7 | 2024 | 6922 | 0.130 |
Why?
|
| Plasma Cells | 1 | 2017 | 84 | 0.130 |
Why?
|
| Budesonide | 1 | 2017 | 46 | 0.130 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2017 | 147 | 0.120 |
Why?
|
| Metagenomics | 3 | 2023 | 101 | 0.120 |
Why?
|
| Wnt-5a Protein | 1 | 2016 | 10 | 0.120 |
Why?
|
| Pouchitis | 1 | 2017 | 57 | 0.120 |
Why?
|
| Antioxidants | 1 | 2017 | 231 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 304 | 0.120 |
Why?
|
| Symbiosis | 4 | 2023 | 128 | 0.120 |
Why?
|
| Sulfoglycosphingolipids | 2 | 2013 | 6 | 0.120 |
Why?
|
| Oligopeptides | 1 | 2017 | 190 | 0.120 |
Why?
|
| Leukemia | 1 | 2018 | 300 | 0.120 |
Why?
|
| Biological Evolution | 2 | 2021 | 1019 | 0.120 |
Why?
|
| Viral Proteins | 1 | 2017 | 247 | 0.120 |
Why?
|
| Bifidobacterium | 1 | 2015 | 18 | 0.120 |
Why?
|
| Glucocorticoids | 2 | 2017 | 360 | 0.120 |
Why?
|
| Colonic Pouches | 1 | 2017 | 97 | 0.120 |
Why?
|
| Receptors, Leukotriene | 1 | 2015 | 10 | 0.120 |
Why?
|
| Amyloidosis | 1 | 2017 | 132 | 0.120 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2017 | 115 | 0.120 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2015 | 21 | 0.120 |
Why?
|
| Interleukin-6 | 2 | 2018 | 276 | 0.110 |
Why?
|
| Child, Preschool | 5 | 2018 | 3781 | 0.110 |
Why?
|
| Duodenum | 4 | 2019 | 111 | 0.110 |
Why?
|
| Immunity, Humoral | 1 | 2015 | 74 | 0.110 |
Why?
|
| Isotretinoin | 1 | 2014 | 20 | 0.110 |
Why?
|
| Aged | 12 | 2024 | 20398 | 0.110 |
Why?
|
| Lymph Nodes | 1 | 2018 | 550 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 2 | 2017 | 833 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 663 | 0.110 |
Why?
|
| Bacterial Proteins | 2 | 2019 | 878 | 0.110 |
Why?
|
| Apoptosis | 2 | 2018 | 1719 | 0.100 |
Why?
|
| Mitochondria | 1 | 2018 | 612 | 0.100 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2014 | 101 | 0.100 |
Why?
|
| Cytostatic Agents | 1 | 2013 | 4 | 0.100 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 1763 | 0.100 |
Why?
|
| Cell Lineage | 3 | 2024 | 321 | 0.100 |
Why?
|
| Dermatologic Agents | 1 | 2014 | 77 | 0.100 |
Why?
|
| Antibodies | 1 | 2015 | 346 | 0.100 |
Why?
|
| Binding Sites | 2 | 2014 | 1126 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2014 | 402 | 0.100 |
Why?
|
| Candidiasis | 1 | 2013 | 39 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 281 | 0.100 |
Why?
|
| Jejunum | 3 | 2010 | 76 | 0.100 |
Why?
|
| B7-H1 Antigen | 1 | 2015 | 305 | 0.100 |
Why?
|
| Coculture Techniques | 2 | 2011 | 170 | 0.100 |
Why?
|
| Perforin | 1 | 2013 | 56 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 2 | 2017 | 1385 | 0.100 |
Why?
|
| Biopsy | 4 | 2019 | 1172 | 0.090 |
Why?
|
| DNA | 3 | 2023 | 1260 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2014 | 774 | 0.090 |
Why?
|
| Clone Cells | 2 | 2023 | 219 | 0.090 |
Why?
|
| Taurocholic Acid | 1 | 2012 | 6 | 0.090 |
Why?
|
| Bilophila | 1 | 2012 | 3 | 0.090 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 253 | 0.090 |
Why?
|
| B-Lymphocytes | 4 | 2024 | 703 | 0.090 |
Why?
|
| Hybridomas | 2 | 2010 | 61 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 600 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 309 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 2485 | 0.090 |
Why?
|
| Stromal Cells | 1 | 2013 | 152 | 0.090 |
Why?
|
| Spleen | 1 | 2013 | 372 | 0.090 |
Why?
|
| Lipids | 1 | 2013 | 277 | 0.090 |
Why?
|
| Transfection | 1 | 2013 | 877 | 0.090 |
Why?
|
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2011 | 6 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 556 | 0.090 |
Why?
|
| Models, Biological | 3 | 2018 | 1768 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2012 | 134 | 0.090 |
Why?
|
| Mice, Inbred NOD | 3 | 2019 | 218 | 0.090 |
Why?
|
| Polyethylene Glycols | 1 | 2013 | 371 | 0.090 |
Why?
|
| Hypersensitivity | 1 | 2013 | 161 | 0.090 |
Why?
|
| Melanoma | 1 | 2015 | 494 | 0.080 |
Why?
|
| Transcriptome | 1 | 2017 | 762 | 0.080 |
Why?
|
| Phenotype | 5 | 2024 | 2545 | 0.080 |
Why?
|
| Gene-Environment Interaction | 1 | 2012 | 120 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2011 | 21 | 0.080 |
Why?
|
| Phylogeny | 2 | 2014 | 1268 | 0.080 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 356 | 0.080 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2011 | 34 | 0.080 |
Why?
|
| Base Sequence | 2 | 2006 | 2207 | 0.080 |
Why?
|
| Bacteroides fragilis | 1 | 2011 | 46 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 1910 | 0.080 |
Why?
|
| Neoplasms, Experimental | 1 | 2012 | 259 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 621 | 0.080 |
Why?
|
| RNA, Long Noncoding | 1 | 2011 | 129 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 91 | 0.080 |
Why?
|
| Gastrointestinal Tract | 2 | 2023 | 196 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 346 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 174 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 441 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2013 | 1518 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2023 | 319 | 0.070 |
Why?
|
| Risk Factors | 5 | 2024 | 5901 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2013 | 1353 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2009 | 672 | 0.070 |
Why?
|
| Cell Degranulation | 1 | 2009 | 14 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 2757 | 0.070 |
Why?
|
| Biomarkers | 2 | 2017 | 1905 | 0.070 |
Why?
|
| Arachidonic Acid | 1 | 2009 | 62 | 0.070 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2010 | 201 | 0.070 |
Why?
|
| Primary Cell Culture | 2 | 2019 | 83 | 0.070 |
Why?
|
| Complementarity Determining Regions | 1 | 2008 | 25 | 0.070 |
Why?
|
| Amides | 1 | 2008 | 54 | 0.070 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 39 | 0.070 |
Why?
|
| Static Electricity | 1 | 2008 | 94 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 98 | 0.070 |
Why?
|
| Cross Reactions | 1 | 2008 | 110 | 0.070 |
Why?
|
| Lactobacillus | 2 | 2019 | 23 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 123 | 0.070 |
Why?
|
| STAT Transcription Factors | 1 | 2008 | 18 | 0.070 |
Why?
|
| Crystallography, X-Ray | 3 | 2017 | 520 | 0.070 |
Why?
|
| Mucous Membrane | 1 | 2008 | 82 | 0.070 |
Why?
|
| Atrophy | 3 | 2022 | 128 | 0.070 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2007 | 13 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 981 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 1517 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 885 | 0.060 |
Why?
|
| Lymphoma | 2 | 2006 | 247 | 0.060 |
Why?
|
| Quorum Sensing | 1 | 2007 | 28 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 1519 | 0.060 |
Why?
|
| Bacillus subtilis | 1 | 2007 | 89 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2008 | 523 | 0.060 |
Why?
|
| Plague Vaccine | 1 | 2006 | 14 | 0.060 |
Why?
|
| Mutation | 2 | 2017 | 4265 | 0.060 |
Why?
|
| Logistic Models | 2 | 2024 | 1241 | 0.060 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2006 | 18 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2006 | 287 | 0.060 |
Why?
|
| Bacterial Vaccines | 1 | 2005 | 44 | 0.060 |
Why?
|
| Colonoscopy | 2 | 2019 | 303 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2020 | 1114 | 0.060 |
Why?
|
| Cytomegalovirus Infections | 1 | 2006 | 111 | 0.060 |
Why?
|
| Molecular Chaperones | 2 | 2016 | 124 | 0.060 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2005 | 56 | 0.060 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2019 | 199 | 0.050 |
Why?
|
| Time Factors | 2 | 2012 | 5380 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 944 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2019 | 1727 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2007 | 661 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2019 | 3044 | 0.050 |
Why?
|
| Enterocytes | 2 | 2018 | 27 | 0.050 |
Why?
|
| CD8 Antigens | 3 | 2017 | 82 | 0.050 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2024 | 30 | 0.050 |
Why?
|
| Caco-2 Cells | 2 | 2018 | 125 | 0.050 |
Why?
|
| Neutrophils | 1 | 2005 | 324 | 0.050 |
Why?
|
| Eye Diseases | 1 | 2024 | 56 | 0.050 |
Why?
|
| Peptides | 2 | 2023 | 653 | 0.050 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2015 | 85 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2019 | 2020 | 0.050 |
Why?
|
| Actinobacillus | 1 | 2023 | 3 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2023 | 3815 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2024 | 264 | 0.050 |
Why?
|
| Receptor Activity-Modifying Protein 1 | 1 | 2022 | 2 | 0.050 |
Why?
|
| Mucus | 1 | 2022 | 19 | 0.050 |
Why?
|
| Nociceptors | 1 | 2022 | 28 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2023 | 111 | 0.050 |
Why?
|
| Immunosuppressive Agents | 2 | 2017 | 987 | 0.050 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2022 | 39 | 0.050 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2002 | 9 | 0.050 |
Why?
|
| Secale | 1 | 2022 | 1 | 0.050 |
Why?
|
| Hordeum | 1 | 2022 | 10 | 0.050 |
Why?
|
| Skin Diseases | 1 | 2024 | 173 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 200 | 0.040 |
Why?
|
| Triticum | 1 | 2022 | 24 | 0.040 |
Why?
|
| Interleukin-17 | 1 | 2023 | 109 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2002 | 44 | 0.040 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2001 | 43 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2022 | 279 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2022 | 101 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 259 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 187 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 1098 | 0.040 |
Why?
|
| Precancerous Conditions | 1 | 2002 | 204 | 0.040 |
Why?
|
| Sex Factors | 1 | 2024 | 1102 | 0.040 |
Why?
|
| Butyric Acid | 1 | 2020 | 12 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 320 | 0.040 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2020 | 16 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2001 | 184 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 367 | 0.040 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 41 | 0.040 |
Why?
|
| Cell Separation | 2 | 2010 | 199 | 0.040 |
Why?
|
| Receptors, Interleukin-15 | 1 | 2019 | 8 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 96 | 0.040 |
Why?
|
| Lymphoma, T-Cell | 1 | 2000 | 60 | 0.040 |
Why?
|
| Infant | 2 | 2011 | 3156 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2019 | 88 | 0.040 |
Why?
|
| Gene Targeting | 1 | 1999 | 72 | 0.040 |
Why?
|
| Placebo Effect | 1 | 2019 | 35 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 50 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 107 | 0.040 |
Why?
|
| Vomiting | 1 | 2019 | 108 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2019 | 244 | 0.040 |
Why?
|
| Edetic Acid | 1 | 2018 | 40 | 0.040 |
Why?
|
| Enzyme Precursors | 1 | 1998 | 20 | 0.040 |
Why?
|
| Myxovirus Resistance Proteins | 1 | 2018 | 7 | 0.040 |
Why?
|
| Netherlands | 1 | 2018 | 25 | 0.040 |
Why?
|
| Eimeria | 1 | 2018 | 1 | 0.040 |
Why?
|
| Collagenases | 1 | 2018 | 42 | 0.040 |
Why?
|
| Paneth Cells | 1 | 2018 | 10 | 0.040 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2018 | 2 | 0.040 |
Why?
|
| Cardiolipins | 1 | 2018 | 16 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 208 | 0.040 |
Why?
|
| France | 1 | 2018 | 52 | 0.030 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2018 | 15 | 0.030 |
Why?
|
| Immunologic Surveillance | 1 | 2018 | 14 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2022 | 891 | 0.030 |
Why?
|
| Gene Expression | 1 | 2002 | 1304 | 0.030 |
Why?
|
| Mitochondrial Membranes | 1 | 2018 | 20 | 0.030 |
Why?
|
| Gene Deletion | 1 | 1999 | 351 | 0.030 |
Why?
|
| Guanosine | 1 | 2018 | 31 | 0.030 |
Why?
|
| Penetrance | 1 | 2018 | 49 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 1998 | 68 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2018 | 137 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2018 | 63 | 0.030 |
Why?
|
| Permeability | 1 | 2018 | 143 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 2018 | 122 | 0.030 |
Why?
|
| Neuroimmunomodulation | 1 | 2017 | 13 | 0.030 |
Why?
|
| Peyer's Patches | 1 | 2017 | 18 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2018 | 291 | 0.030 |
Why?
|
| Selenium | 1 | 2017 | 46 | 0.030 |
Why?
|
| Lysosomes | 1 | 1998 | 123 | 0.030 |
Why?
|
| Leukocyte Immunoglobulin-like Receptor B1 | 1 | 2017 | 2 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 217 | 0.030 |
Why?
|
| Injections, Intradermal | 1 | 2017 | 19 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2017 | 121 | 0.030 |
Why?
|
| Cricetinae | 1 | 2018 | 532 | 0.030 |
Why?
|
| Reoviridae | 1 | 2017 | 6 | 0.030 |
Why?
|
| New Zealand | 1 | 2017 | 23 | 0.030 |
Why?
|
| Plaque, Amyloid | 1 | 2017 | 65 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2017 | 22 | 0.030 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2017 | 18 | 0.030 |
Why?
|
| Vitamins | 1 | 2017 | 85 | 0.030 |
Why?
|
| Capsules | 1 | 2017 | 38 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2017 | 122 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2017 | 80 | 0.030 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2017 | 10 | 0.030 |
Why?
|
| CD4 Antigens | 1 | 2017 | 80 | 0.030 |
Why?
|
| Retreatment | 1 | 2017 | 104 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1998 | 302 | 0.030 |
Why?
|
| Tacrolimus | 1 | 1998 | 372 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 257 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 159 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 958 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2017 | 99 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2017 | 10132 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 709 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 240 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 449 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 7039 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2017 | 4546 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 389 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 985 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 1002 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 1998 | 1014 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 147 | 0.030 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 3 | 2000 | 13 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 827 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2018 | 408 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2016 | 220 | 0.030 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2015 | 32 | 0.030 |
Why?
|
| Vancomycin | 1 | 2015 | 75 | 0.030 |
Why?
|
| Italy | 1 | 2015 | 110 | 0.030 |
Why?
|
| Biodiversity | 1 | 2017 | 239 | 0.030 |
Why?
|
| Sweden | 1 | 2014 | 45 | 0.030 |
Why?
|
| Genotype | 1 | 2019 | 1866 | 0.030 |
Why?
|
| Clonal Deletion | 1 | 2014 | 23 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 1776 | 0.030 |
Why?
|
| Cell Movement | 1 | 2018 | 804 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2017 | 907 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2015 | 117 | 0.030 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2014 | 96 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 1529 | 0.030 |
Why?
|
| Candida albicans | 1 | 2013 | 32 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2013 | 84 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 100 | 0.020 |
Why?
|
| Endoscopy | 1 | 2017 | 366 | 0.020 |
Why?
|
| Acinetobacter baumannii | 1 | 2013 | 27 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2006 | 1099 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2013 | 51 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 2013 | 86 | 0.020 |
Why?
|
| Enterococcus faecalis | 1 | 2013 | 57 | 0.020 |
Why?
|
| Risk | 1 | 2014 | 651 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 537 | 0.020 |
Why?
|
| Phosphates | 1 | 2013 | 161 | 0.020 |
Why?
|
| Immunophenotyping | 2 | 2007 | 224 | 0.020 |
Why?
|
| Virulence | 1 | 2013 | 273 | 0.020 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2014 | 188 | 0.020 |
Why?
|
| Safflower Oil | 1 | 2012 | 7 | 0.020 |
Why?
|
| Taurine | 1 | 2012 | 8 | 0.020 |
Why?
|
| Pyrroles | 1 | 2013 | 165 | 0.020 |
Why?
|
| Genes, MHC Class I | 1 | 2012 | 46 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2012 | 30 | 0.020 |
Why?
|
| Milk | 1 | 2012 | 56 | 0.020 |
Why?
|
| Sulfites | 1 | 2012 | 32 | 0.020 |
Why?
|
| Piperidines | 1 | 2013 | 163 | 0.020 |
Why?
|
| Inclusion Bodies | 1 | 2012 | 31 | 0.020 |
Why?
|
| Bile Acids and Salts | 1 | 2012 | 77 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2011 | 45 | 0.020 |
Why?
|
| Histocompatibility Testing | 1 | 2011 | 140 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 1998 | 1193 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2013 | 382 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2010 | 145 | 0.020 |
Why?
|
| Cecum | 1 | 2010 | 78 | 0.020 |
Why?
|
| Caspases | 1 | 2010 | 151 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2010 | 84 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 273 | 0.020 |
Why?
|
| Dimerization | 1 | 2010 | 148 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2010 | 111 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 2012 | 260 | 0.020 |
Why?
|
| Pregnancy | 1 | 2017 | 3128 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 300 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 391 | 0.020 |
Why?
|
| Registries | 1 | 2014 | 995 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2010 | 157 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2018 | 9074 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2010 | 196 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 1849 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2015 | 1416 | 0.020 |
Why?
|
| Oxazoles | 1 | 2008 | 13 | 0.020 |
Why?
|
| Alleles | 1 | 2011 | 1139 | 0.020 |
Why?
|
| Granzymes | 1 | 2008 | 94 | 0.020 |
Why?
|
| Catalysis | 1 | 2008 | 215 | 0.020 |
Why?
|
| Kinetics | 1 | 2010 | 1463 | 0.020 |
Why?
|
| Lactoglobulins | 1 | 2007 | 6 | 0.020 |
Why?
|
| Solute Carrier Family 22 Member 5 | 1 | 2007 | 5 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2008 | 86 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2007 | 18 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2007 | 120 | 0.020 |
Why?
|
| Brain | 1 | 2017 | 2337 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2000 | 888 | 0.020 |
Why?
|
| Genome, Human | 1 | 2011 | 823 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2006 | 103 | 0.010 |
Why?
|
| Transformation, Bacterial | 1 | 2005 | 5 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2005 | 25 | 0.010 |
Why?
|
| Fluorescence | 1 | 2005 | 100 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 638 | 0.010 |
Why?
|
| Paris | 1 | 2004 | 5 | 0.010 |
Why?
|
| Microvilli | 1 | 2004 | 44 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2005 | 348 | 0.010 |
Why?
|
| New York City | 1 | 2004 | 69 | 0.010 |
Why?
|
| Homozygote | 1 | 2004 | 206 | 0.010 |
Why?
|
| Vaccination | 1 | 2006 | 303 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2005 | 517 | 0.010 |
Why?
|
| Mitosis | 1 | 2004 | 151 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 435 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 550 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 726 | 0.010 |
Why?
|
| Diarrhea | 1 | 2004 | 176 | 0.010 |
Why?
|
| New York | 1 | 2003 | 78 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 206 | 0.010 |
Why?
|
| United States | 1 | 2015 | 7581 | 0.010 |
Why?
|
| Diet, Protein-Restricted | 1 | 2000 | 3 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2000 | 291 | 0.010 |
Why?
|
| Comorbidity | 1 | 2003 | 1003 | 0.010 |
Why?
|
| Epithelium | 1 | 2000 | 314 | 0.010 |
Why?
|
| Incidence | 1 | 2003 | 1697 | 0.010 |
Why?
|
| Syk Kinase | 1 | 1998 | 8 | 0.010 |
Why?
|
| Endosomes | 1 | 1998 | 86 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2000 | 456 | 0.010 |
Why?
|
| Biological Transport | 1 | 1998 | 398 | 0.010 |
Why?
|
| Communicable Diseases | 1 | 1998 | 69 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1998 | 392 | 0.010 |
Why?
|
| Survival Rate | 1 | 2000 | 1945 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2003 | 2434 | 0.010 |
Why?
|
| Prognosis | 1 | 2000 | 3891 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 4028 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1998 | 2552 | 0.000 |
Why?
|